![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2021
Wollenberg, A.; Nakahara, T.; Maari, C.; Peris, K.; Lio, P.; Augustin, M.; Silverberg, J. I.; Rueda, M. J.; DeLozier, A. M.; Pierce, E.; Yang, F. E.; Sun, L.; Ball, S.; Tauber, M. und Paul, C.
(2021):
Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial.
In: Journal of the European Academy of Dermatology and Venereology, Bd. 35, Nr. 7: S. 1543-1552
2020
Reich, K.; DeLozier, A. M.; Nunes, F. P.; Thyssen, J. P.; Eichenfield, L. F.; Wollenberg, A.; Terres, J. A. Ross; Watts, S. D.; Chen, Y-F; Simpson, E. L. und Silverberg, J.
(2020):
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.
In: Journal of Dermatological Treatment
Simpson, E. L.; Lacour, J.-P.; Spelman, L.; Galimberti, R.; Eichenfield, L. F.; Bissonnette, R.; King, B. A.; Thyssen, J. P.; Silverberg, J. I.; Bieber, T.; Kabashima, K.; Tsunemi, Y.; Costanzo, A.; Guttman-Yassky, E.; Beck, L. A.; Janes, J. M.; DeLozier, A. M.; Gamalo, M.; Brinker, D. R.; Cardillo, T.; Nunes, F. P.; Paller, A. S.; Wollenberg, A. und Reich, K.
(2020):
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials.
In: British Journal of Dermatology, Bd. 183, Nr. 2: S. 242-255